Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Jul 14, 2025

SELL
$47.74 - $65.16 $42,870 - $58,513
-898 Closed
0 $0
Q4 2024

Jul 14, 2025

BUY
$42.57 - $61.09 $11,791 - $16,921
277 Added 44.61%
898 $42.9 Million
Q3 2024

Jul 14, 2025

BUY
$51.3 - $64.42 $31,857 - $40,004
621 New
621 $35.5 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $9.75B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Painted Porch Advisors LLC Portfolio

Follow Painted Porch Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Painted Porch Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Painted Porch Advisors LLC with notifications on news.